Irene Hutchins
Hematology & Oncology · Palm Springs, CANPI 1639435407
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $12,365 of the $17,202 with a category attached, or 71.9%. 36 manufacturers reported payments, led by Genentech USA, Inc. at 50.6% of the total. Reporting peaked in 2020 at $17,200 and has fallen 99.9% since, to $17 in 2021.
Across 119 payments — averaging $191.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$12K
- Bristol Myers Squibb$7K
- Johnson & Johnson$2K
- E.r. Squibb & Sons, L.L.C.$462
- AstraZeneca$408
- Merck$305
- plus $1K from 30 others
What the payments were for
- Consulting fees$12,36572%
- Speaking & faculty fees$1,1307%
- Travel & lodging$8525%
- Food & beverage$2,79916%
- Education$560%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 5 | $11,538 |
| Bristol Myers Squibb | 6 | $6,673 |
| Johnson & Johnson(2 entities) | 5 | $2,014 |
| E.r. Squibb & Sons, L.L.C. | 33 | $462 |
| AstraZeneca | 11 | $408 |
| Merck | 12 | $305 |
| Amgen | 6 | $214 |
| Jazz Pharmaceuticals Inc. | 3 | $166 |
| Novartis | 2 | $146 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $123 |
| Medtronic | 1 | $113 |
| Janssen Scientific Affairs, LLC | 2 | $61 |
| Pfizer | 3 | $57 |
| AMAG Pharmaceuticals, Inc. | 3 | $56 |
| EMD Serono, Inc. | 2 | $41 |
| AbbVie | 2 | $38 |
| Astellas Pharma US Inc | 2 | $37 |
| Array Biopharma Inc | 2 | $25 |
| Tolmar Pharmaceuticals, Inc. | 1 | $25 |
| Kyowa Kirin, Inc. | 1 | $22 |
| Verastem, Inc. | 1 | $22 |
| Secura Bio, Inc. | 1 | $21 |
| Clovis Oncology, Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Foundation Medicine, Inc. | 1 | $20 |
| Rigel Pharmaceuticals, Inc. | 1 | $20 |
| Mylan Institutional Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Bayer | 1 | $17 |
| Monteris Medical Corporation | 1 | $16 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $16 |
| Sanofi | 1 | $14 |
| Incyte Corporation | 1 | $14 |
| Dova Pharmaceuticals | 1 | $13 |
| Puma Biotechnology, Inc. | 1 | $13 |
| Boehringer Ingelheim | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$22,801 in reported general payments places this provider in the 80th percentile of 1,363 hematology & oncology providers in California.
Other hematology & oncology in Palm Springs
- Dennis SlamonLos Angeles$3.1M
- Sandra HorningStanford$2.5M
- Mohammadbagher ZiariCorona$2.5M
- George YaghmourLos Angeles$1.9M
- Robert VescioWest Hollywood$1.1M
- Kevin KellyLos Angeles$894K
- Johnny ChangEncino$884K
- Nitin RohatgiSacramento$814K
- Omid HamidSanta Monica$809K
- Catherine CoombsOrange$786K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.